In today’s rapidly-changing world, clients require partners that value innovation as much as entrepreneurship, global connections as much as local knowledge. International law firm ZAG-S&W is that partner.

With offices in the U.S., China, Israel and London, ZAG-S&W’s widely recognized Corporate department provides an integrated raft of services to major domestic and international companies in all stages of development, and from across many industry sectors, including pharmaceuticals, technology, real estate, trade and industry, banking, energy, and many more.

These clients trust our global insight and substantial experience in creating and implementing joint venture, partnership and shareholder agreements, mergers and acquisitions, capital markets transactions, private equity and venture capital investments, public and private debt financings, general corporate and commercial agreements, and much, much more.

We believe that clients are at a distinct advantage when working with our team of seasoned professionals who understand their businesses, speak their language and share their objectives.

Furthermore, backed by our global resources, we constantly strive to connect and introduce our clients to the right professionals in order to gain a competitive edge and take their businesses forward.

  • Represented a telecommunications company’s IPO and counseled on other offerings of equity and debt securities valued at more than $5 billion.
  • Represented American Tower Corporation’s $260 million cash purchase of 2,000 communication towers (including a build-to-suit for an additional 1,000 towers) from AT&T Corp.
  • Represented  and counseled a U.S. borrower on its $650 million syndicated multi-currency credit agreement.
  • Represented an institutional investor in civil and criminal proceedings to recover losses from a rogue employee’s off-market trading of more than $9 billion in securities.
  • Represented a financial services company in switching its listing from NASDAQ to NYSE.
  • Represented a leading venture capital fund with more than $1.6 billion in committed capital under management; facilitated the fund’s first “going-private” transaction with a publicly-traded enterprise.
  • Ensure observance of Sarbanes-Oxley Act requirements, stock exchange listing standards, fiduciary duties and state law governance practices.
  • Represented New York Global Innovations Inc. (NYGI) in its reverse triangular merger, On August 23, 2016, the Company entered into the Merger Agreement with Artemis and the Subsidiary, pursuant to which Artemis merged with and into the Subsidiary, with Artemis being the surviving entity. Following the Merger, the Company adopted the business plan of Artemis.
  • Represented NYGI as a reporting company that is traded “over the counter” in the United States, under the ticker symbol INKS.
  • Represented Advanced Inhalation Therapies (AIT) Ltd with legal advice regarding Israeli law pertaining to a reverse subsidiary merger, according to which Red Maple Ltd., a wholly owned Israeli subsidiary of a US shell company by the name of AIT Therapies Ltd., was merged into the company, in the scope of an investment of approximately US$ 10,000,000 in the company.
  • Represented Tomatech R&D (Israel) Ltd. In a transaction investment and purchase of membership interests of Tomatech LLC, the US parent company of Tomatech R&D (Israel), such that following said transactions, the investor shall hold 50% of Tomtech LLC.
  • Represented Chicago IVF International, LLC in Shares Purchase, Licensing agreement and Joint Venture transaction agreement. The Company has purchased 20% shares in the Chinese JV Medicess Medical Technology (Shanghai) Co., Ltd.
  • Represented Rimoni Industries Ltd (“Rimoni”) in the transaction for purchasing 100% of the business activity and assets of Friedrich Plastic Industry Ltd. (previously Friedrich Molds Ltd.) (“Friedrich”). Adv. Reut Alfiah, a partner in the ZAG S&W team, represented Rimoni in negotiations with Friedrich trustees, through court discussions in order to approve the transaction (Friedrich was at the time in Stay of Proceedings), and for getting the Antitrust Authority approval for the transaction.
  • Represented Espro, drafted and negotiated the structure of the deal and the SPA, reviewed the SPA in chinese and provided legal advice in its investment round of $4Million by the Chinese investor Zhejiang Zhuo Rui Technology Co., Ltd.
  • Represented Nano Textile, drafted and negotiated the structure of the deal and the SPA, reviewed the SPA in chinese and provided legal advice in its investment round of $2Million by the Chinese investors: Zhongguancun Translational Medicine Science & Technology Co., Ltd., Chongqing Liangjiang Yuanchuang Translational Medicine Science & Technology Co., Ltd.,Beijing BASIBA Biomedical Engineering Science & Technology Development Co., Ltd. and Beijing Jishi Daze Biological Science & Technology Center.
  • Represented Betalin, drafted and negotiated the structure of the deal and the SPA, reviewed the SPA in chinese and provided legal advice in its investment round of $1.5Million by the Chinese investors.
  • Represented the company, HAM-LET (ISRAEL-CANADA) Ltd in its on-going contracts with the local government for compensation and investment in a new plant.
  • Represented MIS Implants Technologies in their ongoing operation in China.









Recent Activity